U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"The production of too many useful things results in too many useless people."

Karl Marx

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Assignee: United States of America, Represented by the Secretary, Department of Health and Human Services


Location: Washington, DC
No. of patents: 11

NumberTitleIssue Date
7276227Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
The present invention relates to a purified or isolated obligate domain-swapped dimer of CVN and a composition comprising the same. ...
10/02/2007
7271150Modified growth hormone
The invention provides a growth hormone (GH) in which amino acids within the regulated secretory pathway (RSP) sorting signal have been mutated as well as a GH in which the three-dimensional conformation of the RSP sorting signal has been altered, and a composition ...
09/18/2007
7271002Production of adeno-associated virus in insect cells
A method of producing an adeno-associated virus (AAV) in an insect cell comprising (i) providing at least one insect cell-compatible vector comprising a first nucleotide sequence comprising at least one AAV ITR nucleotide sequence, a second nucleotide sequence conta...
09/18/2007
7247615Peptide agonists of prostate-specific antigen and uses therefor
This invention relates to isolated peptides comprising agonist epitopes of prostate-specific antigen (PSA). In various aspects, the invention relates to peptides comprising agonist epitopes of the PSA-3 cytotoxic T lymphocyte epitope, and nucleic acids encoding pept...
07/24/2007
7244724Pyrrolobenzodiazepines
A compound of formula I: or solvate thereof, wherein n is 1 to 10, and M and M′ are independently selected from monovalent pharmaceutically acceptable cations, or together represent a divalent pharmaceutically ...
07/17/2007
7232887Melanoma antigens and their use in diagnostic and therapeutic methods
The present invention provides a nucleic acid sequence encoding a melanoma antigen recognized by T lymphocytes, designated MART-1. This invention further relates to bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, asses...
06/19/2007
7226991Phenylalanine derivatives
Disclosed herein are phenylalanine derivative compounds of the following formula W—Y—(AA)n—Z wherein Y is a phenylalanyl radical, AA is an amino acid, n is an integer of 1 to 15, and substituent variables W and Z are as described...
06/05/2007
7223844Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by Env-CD4-co-receptor complexes
The present invention features antibodies and antibody fragments that specifically bind a CD4-inducible HIV gp120 epitope that is enhanced by binding a co-receptor for HIV, such as CCR5 or CXCR4, and pharmaceutical compositions comprising the antibodies or antibody ...
05/29/2007
7214488Detection of MECT1-MAML2 fusion products
The present invention provides methods and compositions for the diagnosis and treatment of cancer, including cancers involving the NOTCH pathway. In particular, the present invention provides methods and compositions for the diagnosis of mucoepidermoid carcinoma, th...
05/08/2007
7205334Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof
A substantially purified compound of the formula: a composition comprising a therapeutically effective amount of at least one compound of the formula, alone or in combination with at least one additional therapeutic agent, and methods of preventing or treating cance...
04/17/2007
7199127Purine nucleosides
Disclosed are purine nucleoside compounds that are selective to A3 adenosine receptors and are useful for the treatment of cancer and inflammatory diseases. The compounds are shown by the following general formula (I), including isomers thereof:
04/03/2007
 
Sign InRegister
Username  
Password   
forgot password?